COMP <GO>
RCUS vs PBH // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Arcus Biosciences Inc. (NYSE) VS. Prestige Consumer Healthcare Inc. (NYSE) • 15-METRIC TALLY: RCUS 1
— PBH 7
■ METRIC PARITY
LAST: $18.61 (+1.20%) • MKT CAP: $2.37B
options-implied-move
—
LAST: $48.75 (+2.01%) • MKT CAP: $2.31B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RCUS VS. PBH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RCUS | PBH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 54.70% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 13.80% | -48.80 | PBH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 7.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -20.42% | 10.67% | -31.09 | PBH | /fcf-yield <GO> |
| Operating Margin | -60.00% | 28.40% | -88.40 | PBH | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 17.50% | -77.50 | PBH | /net-margins <GO> |
| Revenue Growth (YoY) | -35.30% | -4.30% | -31.00 | PBH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 2.21 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 6/9 | -5.00 | PBH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 33.1 | 52.5 | -19.40 | PBH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 11.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.37B | $2.31B | $60.2M | RCUS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RCUS REV | PBH REV | RCUS GROSS % | PBH GROSS % | RCUS FCF | PBH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $33.0M | $1.09B | — | 54.7% | -$484.0M | $246.4M |
| FY 2024 | $51.0M | $1.14B | — | 55.8% | -$176.0M | $243.3M |
| FY 2023 | $37.0M | $1.13B | — | — | -$306.0M | $248.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RCUS // BETA —
PBH // BETA —